Results 11 to 20 of about 20,877 (202)
Pancytopenia associated with clonazepam [PDF]
Journal of Hematology & Oncology, 2010 We report a case of a 48-year-old Chinese female with end-stage renal disease and chronic anemia on hemodialysis. Clonazepam was prescribed for myoclonus disorder two weeks prior to her hospitalization.
Hsueh Chung-Tsen +2 more
doaj +2 more sources
Association of oxamniquine praziquantel and clonazepam in experimental Schistosomiasis mansoni [PDF]
Memorias do Instituto Oswaldo Cruz, 2008 The antischistosomal activity of clonazepam, when administered alone or in association with oxamniquine and praziquantel, was experimentally evaluated in mice infected with Schistosoma mansoni.
Neusa Araujo +3 more
doaj +3 more sources
Hyperekplexia; Response to Clonazepam
Pediatric Neurology Briefs, 1992 Sixteen patients, including 1 neonate, in a large 5 generation family with hyperekplexia (startle disease or congenital stiff-man syndrome) were treated with clonazepam at the University of Texas Health Science Center, San Antonio, TX.
J Gordon Millichap
doaj +2 more sources
Psychopharmacotherapy of panic disorder: 8-week randomized trial with clonazepam and paroxetine [PDF]
Brazilian Journal of Medical and Biological Research, 2011 The objective of the present randomized, open-label, naturalistic 8-week study was to compare the efficacy and safety of treatment with clonazepam (N = 63) and paroxetine (N = 57) in patients with panic disorder with or without agoraphobia.
A.E. Nardi +20 more
doaj +4 more sources
Clonazepam-induced acute bilateral transient myopia
The Pan-American Journal of Ophthalmology, 2021 Clonazepam belongs to the benzodiazepine group of drugs and has a quick onset and prolonged duration of action. It is frequently prescribed for treatment of anxiety disorder and panic attacks. Benzodiazepines are known to induce angle closure glaucoma in
Singh Swati, Koul Akanksha
doaj +1 more source
Frontiers in Nutrition, 2020 Background: Clonazepam (CNZP) is effective in ~90% of patients with rapid eye movement sleep behavior disorder (RBD) but has risks of oversedation, muscular relaxation, and adverse effects on cognitive function when used to treat RBD associated with ...
Yuta Manabe, Yuta Manabe, Yuta Manabe
doaj +1 more source
Carbon dioxide test as an additional clinical measure of treatment response in panic disorder [PDF]
Arquivos de Neuro-Psiquiatria, 2002 OBJECTIVE: We aim to determine if a treatment with a dose of clonazepam - 2 mg/day, for 6 weeks, blocks spontaneous panic attacks and the ones induced by the inhalation of 35% carbon dioxide (CO2) in panic disorder (PD) patients.
Alexandre M. Valença +4 more
doaj +1 more source
A Case Report of Excessive Use of Clozapine Combined With Clonazepam
Frontiers in Psychiatry, 2022 IntroductionFor patients with schizophrenia, clozapine (CLZ) in combination with clonazepam (CLNAZ) is one of the viable therapeutic options. We successfully reduced the doses of CLZ and CLNAZ to the safe range of a polydrug abuse patient.
Wei Li +9 more
doaj +1 more source
Association between venous anomaly of the cerebellum and tremor
Liječnički vjesnik, 2023 Tremor is an involuntary movement of a body part that often occurs due to damage to the extrapyramidal system. Action-intention tremor usually occurs in ipsilateral lesions of the cerebellum.
Martina Periša +2 more
doaj +1 more source
Optimization of clonazepam therapy adjusted to patient's CYP3A-status and NAT2 genotype [PDF]
, 2016 BACKGROUND: The shortcomings of clonazepam therapy include tolerance, withdrawal symptoms and adverse effects, such as drowsiness, dizziness and confusion leading to increased risk of falls.
Tóth, Katalin +8 more
core +3 more sources